Elixir Medical Corporation
Records under this name other than the patents Elixir Medical Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 32 patents it holds.
Showing 1 to 4 of 4 · Back to Elixir Medical Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,350,093 | Degradable implantable medical devices Term ended Term ended Apr 4, 2026 · USPTO record | Term ended | Term ended Apr 4, 2026 | USPTO record |
| US 8,404,641 | Macrocyclic lactone compounds and methods for their use Lapsed on the fee record Ended Mar 26, 2025 · USPTO record | Lapsed on the fee record | Ended Mar 26, 2025 | USPTO record |
| US 9,566,371 | Biodegradable endoprostheses and methods for their fabrication Lapsed on the fee record Ended Feb 14, 2025 · USPTO record | Lapsed on the fee record | Ended Feb 14, 2025 | USPTO record |
| US 8,367,081 | Macrocyclic lactone compounds and methods for their use Lapsed on the fee record Ended Feb 5, 2025 · USPTO record | Lapsed on the fee record | Ended Feb 5, 2025 | USPTO record |